The former vice president of a Carmel Valley pharmaceutical company pleaded guilty Friday to a federal securities fraud count.

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted ... guilty today to a federal securities fraud count for insider trading. George Demos, 64, formerly of Acadia Pharmaceuticals ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

George Demos, former vice president of drug safety and pharmacovigilance at Acadia Pharmaceuticals Inc., is the latest biopharma executive to plead guilty to insider trading charges. BioWorld ...

The former vice president of a San Diego-based pharmaceutical company pleaded guilty Friday to a federal securities fraud count for insider trading ... 64, formerly of Acadia Pharmaceuticals ...